Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.

Hofma SH, Brouwer J, Velders MA, van't Hof AW, Smits PC, Queré M, de Vries CJ, van Boven AJ.

J Am Coll Cardiol. 2012 Jul 31;60(5):381-7. doi: 10.1016/j.jacc.2012.01.073.

2.

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, Genereux P, Stone GW.

J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6. Review.

3.

Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials.

Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, Sangiorgi D, Bacchi Reggiani L, Kaiser C, Kim HS, De Waha A, Ribichini F, Stone GW.

Circ Cardiovasc Interv. 2012 Jun;5(3):357-64. doi: 10.1161/CIRCINTERVENTIONS.111.967083. Epub 2012 Jun 5. Review.

4.

Stent thrombosis with drug-eluting stents: is the paradigm shifting?

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Genereux P, Branzi A, Stone GW.

J Am Coll Cardiol. 2013 Nov 19;62(21):1915-21. doi: 10.1016/j.jacc.2013.08.725. Epub 2013 Sep 11. Review.

5.

Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

Park KW, Kang SH, Velders MA, Shin DH, Hahn S, Lim WH, Yang HM, Lee HY, Van Boven AJ, Hofma SH, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Kim HS.

Am Heart J. 2013 Feb;165(2):241-50.e4. doi: 10.1016/j.ahj.2012.08.007. Epub 2012 Dec 27. Review.

PMID:
23351828
6.

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).

Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G.

Vasc Health Risk Manag. 2008;4(1):31-8. Review.

7.

Long-term effect of second-generation drug-eluting stents for coronary artery disease, everolimus-eluting versus zotarolimus-eluting stents: a meta-analysis.

Qi-Hua L, Qi Z, Yu Z, Xiao-Long L, Hai-Gang J, Jian-Feng Y, Yi S.

Coron Artery Dis. 2015 May;26(3):259-65. doi: 10.1097/MCA.0000000000000222. Review.

PMID:
25715339
8.

Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials.

Piccolo R, Cassese S, Galasso G, Niglio T, De Rosa R, De Biase C, Piscione F.

Clin Res Cardiol. 2012 Nov;101(11):885-93. doi: 10.1007/s00392-012-0472-y. Epub 2012 May 16. Review.

PMID:
22588843
9.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
10.

Meta-analysis of long-term clinical outcomes of everolimus-eluting stents.

Toyota T, Shiomi H, Morimoto T, Kimura T.

Am J Cardiol. 2015 Jul 15;116(2):187-94. doi: 10.1016/j.amjcard.2015.03.059. Epub 2015 Apr 16. Review.

PMID:
25960378
11.

Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis.

Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blöchlinger S, Heg D, Jüni P, Windecker S.

Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e002223. doi: 10.1161/CIRCINTERVENTIONS.114.002223. Review.

12.

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.

Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Cohen DJ, Hwang SS, Kim HS.

Eur Heart J. 2014 May;35(17):1147-58. doi: 10.1093/eurheartj/eht570. Epub 2014 Jan 23. Review.

13.

Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Wirianta J, Lee JH, Kaiser C, Di Lorenzo E, Suryapranata H.

J Thromb Thrombolysis. 2014 Oct;38(3):355-63. Review.

PMID:
24659172
14.

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.

Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Epub 2012 May 4. Review.

PMID:
22562999
15.

Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis.

Li P, Liu JP.

Coron Artery Dis. 2014 Aug;25(5):369-77. doi: 10.1097/MCA.0000000000000109. Review.

PMID:
24818639
16.

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison.

Cassese S, Ndrepepa G, King LA, Tada T, Fusaro M, Kastrati A.

Heart. 2012 Nov;98(22):1632-40. doi: 10.1136/heartjnl-2012-302519. Epub 2012 Sep 4. Review.

PMID:
22949487
18.
19.

Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarction.

Wang L, Wang H, Dong P, Li Z, Wang Y, Duan N, Zhao Y, Wang S.

Arq Bras Cardiol. 2014 Jun;102(6):529-38. Epub 2014 Jun 6. Review. English, Portuguese.

20.

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT Cooperation.

Am J Cardiol. 2013 May 1;111(9):1295-304. doi: 10.1016/j.amjcard.2013.01.281. Epub 2013 Mar 12. Review.

PMID:
23490029
Items per page

Supplemental Content

Write to the Help Desk